New Jersey AR 30: Urges US FDA to reconsider approval of Zohydro ER pending comprehensive testing.

Status: Filed with Secretary of State (as of 2017-02-15)

State: New Jersey · Session: 217 · Bill: AR 30

Subjects: DRUG ABUSE, PHARMACEUTIC

Sponsors: Jimenez, Angelica M., Lagana, Joseph A.

View New Jersey AR 30 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.